November 04, 2016
1 min read
Save

Cardiology Today's top 5 posted in the previous month

Cardiology Today compiled a list of the top 5 stories posted to Healio.com/Cardiology in October.

This month, Cardiology Today readers were most interested in presentation data from the Cardiometabolic Health Congress, including; the role of triglyceride-rich lipoproteins in CV risk, effects of lower BP on diabetes, SGLT2 inhibitors, the role of warfarin and oral anticoagulants in patients with atrial fibrillation, the link between bariatric surgery and a further understanding of obesity and much more.

 

Triglyceride-rich lipoproteins play causal role in CV risk

BOSTON — Genetic and observational studies have demonstrated that triglyceride-rich lipoproteins play a causal role in CV risk, and raising HDL has no effect on CV outcomes.

Read More

 

Lower BP confers better outcomes, even in patients with diabetes
BOSTON — The SPRINT trial and several meta-analyses suggest that more intensive reduction of systolic BP leads to better CV outcomes, but uncertainty remains about how much lower is better, and individual clinical judgment is paramount, an expert said at the Cardiometabolic Health Congress.

Read More

 

For SGLT2 inhibitors, big benefits come with some trade-offs

BOSTON — The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults with type 2 diabetes; however, the class is associated with possible side effects that should be carefully considered.

Read More

 

Merits of warfarin, newer oral anticoagulants for patients with AF debated

BOSTON — At the Cardiometabolic Health Congress, one expert argued that warfarin remains the safe and effective gold standard for patients requiring oral anticoagulation, whereas another said the newer oral anticoagulants should be used in patients with AF.

Read More

 

Bariatric surgery ‘powerful’ tool for understanding biology of obesity
BOSTON — A physiological regulation of energy balance drives most obesogenic behavior, and bariatric surgery is likely to best option to “rewire the body” to respond to environmental factors in a healthier way.

Read More